The Health Ministry will announce a mechanism to deliver monthly medications for patients, and any emergency drugs through health centers under the supervision of voluntary medical teams, an official said today. Director of the Amman Health Directorate, Nayef Zaben stated that the move comes after the closure of health centers that provide primary and comprehensive care as part of the measures to slow the spread of the COVID-19. In cases of emergency, the Civil Defense Directorate's crews will evacuate the patient to a hospital in an effort to prevent overcrowding and safeguard citizens, he pointed out. Last Updated: 2020-03-22 15:51
The Minister of Health, Saad Jaber, has announced that 40 new coronavirus cases were recorded today in Jordan, bringing the total number of cases to 212, including the patients who recovered. During a press briefing at the National Center for Security and Crisis Management, the Minister said that 26 cases were reported in Irbid governorate. However, 19 cases were reported in Amman, five of whom were in quarantine after they returned from abroad. Jaber stressed that the sudden rise in numbers is a dangerous indicator. The Minister urged Jordanians to stay home and to follow the instructions during this period
The Minister of State for Media Affairs, Amjad Adaileh, has confirmed that that the imposed curfew will not be lifted on Tuesday, March 24, according to Jordan's Al Ra'i newspaper. Adaileh added that people will not be allowed to leave their homes unless necessary. He pointed out that the government will announce a number of proposals through which the basic needs will be delivered to citizens.
Hanan Sboul takes over the position of IGBA Chair For immediate release Geneva, 7 January 2020 IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, announced today that Hanan Sboul, Secretary General of the Jordanian Association of Pharmaceutical Manufacturers, is taking over the position of IGBA Chair for 2020 from Jim Keon, President of the Canadian Generic Pharmaceutical Association and Biosimilars Canada. Key milestones were achieved for the IGBA during 2019, namely the signature of a memorandum of understanding with the World Health Organization (WHO) to promote access i and the adoption
In cooperation with JFDA, JAPM held a workshop for members and nonmembers entitled: “Pharmacovigilance in Practice” Speakers from the Rational Dug Use Department/ JFDA covered the following topics: Reporting ADRs Lessons to Be Learned What’s Beyond Safety Agreement Why Collecting Medication Errors, Drug Misuse, Abuse, Overdose, Off Label use Major Deficiencies during PV-Inspection Perceived Impact of RMP & PSUR on the Leaflet Phase IV Studies, Where We Stand? It is worth mentioning that; this workshop comes as a continues cooperation between JAPM and the JFDA to achieve the growth and development of the Jordanian pharmaceutical industry by holding workshops for